An acyclic nucleic acid-modified siRNA targeting CAG expansions for polyglutamine disease treatment

Polyglutamine (polyQ) diseases are inherited neurological disorders caused by an expansion of the cytosine-adenine-guanine (CAG) repeat in the causative genes. These include Huntington’s disease, spinal and bulbar muscular atrophy (SBMA), and spinocerebellar ataxias (SCAs). Clinical trials have been...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Kentaro Maeda, Tomoki Hirunagi, Kentaro Sahashi, Yukiko Kamiya, Madoka Iida, Kenji Sakakibara, Kazunari Onodera, Manabu Ohyama, Yohei Okada, Hideyuki Okano, Hiroyuki Asanuma, Masahisa Katsuno
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Elsevier 2026-03-01
Saila:	Molecular Therapy: Nucleic Acids
Gaiak:	MT: Oligonucleotides: Therapies and Applications siRNA CAG repeat allele selective polyglutamine diseases SBMA
Sarrera elektronikoa:	http://www.sciencedirect.com/science/article/pii/S2162253125003567
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!